Therapy-induced developmental reprogramming of prostate cancer cells and acquired therapy resistance-Reference-Cited by-同舟云学术

Therapy-induced developmental reprogramming of prostate cancer cells and acquired therapy resistance

Published:2017-01-27 Issue:12 Volume:8 Page:18949-18967
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Nouri Mannan¹²,Caradec Josselin¹²,Lubik Amy Anne¹²,Li Na¹,Hollier Brett G.³,Takhar Mandeep⁴,Altimirano-Dimas Manuel¹,Chen Mengqian⁵,Roshan-Moniri Mani¹,Butler Miriam¹,Lehman Melanie³,Bishop Jennifer¹,Truong Sarah¹,Huang Shih-Chieh¹,Cochrane Dawn⁶,Cox Michael¹²,Collins Colin¹²,Gleave Martin¹²,Erho Nicholas⁴⁷,Alshalafa Mohamed⁴,Davicioni Elai⁴⁷,Nelson Colleen¹³,Gregory-Evans Sheryl⁸,Karnes R. Jeffrey⁹,Jenkins Robert B.¹⁰,Klein Eric A.¹¹,Buttyan Ralph¹²

Affiliation:

1. Vancouver Prostate Centre, Vancouver, Canada

2. Department of Urologic Sciences, University of British Columbia, Vancouver, Canada

3. Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Australia

4. GenomeDX Biosciences, Vancouver, Canada

5. Drug Discovery & Biomedical Sciences, South Carolina College of Pharmacy, Columbia, South Carolina, USA

6. Department of Molecular Oncology, British Columbia Cancer Agency, Vancouver, Canada

7. GenomeDX Biosciences, San Diego, California, USA

8. Department of Ophthalmology and Visual Sciences, University of British Columbia, Vancouver, Canada

9. Department of Urology, Mayo Clinic, Rochester, Minnesota, USA

10. Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA

11. Glickman Urological and Kidney Institute, Cleveland Clinic Foundation, Cleveland, Ohio, USA

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting valine catabolism to inhibit metabolic reprogramming in prostate cancer;Cell Death & Disease;2024-07-18

2. ONECUT2 acts as a lineage plasticity driver in adenocarcinoma as well as neuroendocrine variants of prostate cancer;Nucleic Acids Research;2024-06-27

3. Valine Catabolism Drives Bioenergetic and Lipogenic Fuel Plasticity in Prostate Cancer;2024-01-02

4. ONECUT2 Activates Diverse Resistance Drivers of Androgen Receptor-Independent Heterogeneity in Prostate Cancer;2023-10-01

5. Genomic Evolution and Transcriptional Changes in the Evolution of Prostate Cancer into Neuroendocrine and Ductal Carcinoma Types;International Journal of Molecular Sciences;2023-08-12